The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Mao, Yubin ^a   Xu, Jinfei ^a   Li, Zhihan ^a   Zhang, Nini ^a   Yin, Hao ^a   Liu, Zuguo ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST 2; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER STAGING; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METASTASIS; OVARY CANCER; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; TISSUE MICROARRAY; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; ADENOMATOUS POLYPOSIS COLI PROTEIN; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL NUCLEUS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; REPRESSOR PROTEINS; TWIST TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84892942993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078200     Document Type: Article

References (36)

1. Khalil I, Brewer MA, Neyarapally T, Runowicz CD (2010) The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer. Gynecol Oncol 116: 282-285.
2. Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, et al. (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5: e232.
3. Ahmed N, Abubaker K, Findlay J, Quinn M (2010) Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 10: 268-278.
4. Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, et al. (2010) Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 291: 59-66.
5. Geiger TR, Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308.
6. Zlobec I, Lugli A (2010) Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget 1: 651-661.
7. Haslehurst AM, Koti M, Dharsee M, Nuin P, Evans K, et al. (2012) EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer 12: 91.
8. Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, et al. (2010) ERalpha signaling through slug regulates E-cadherin and EMT. Oncogene 29: 1451-1462.
9. Sanchez-Tillo E, Lazaro A, Torrent R, Cuatrecasas M, Vaquero EC, et al. (2010) ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Oncogene 29: 3490-3500.
10. Fang X, Cai Y, Liu J, Wang Z, Wu Q, et al. (2011) Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 30: 4707-4720.
11. Li Y, Wang W, Yang R, Wang T, Su T, et al. (2012) Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol 124: 112-118.
12. Zhou C, Liu J, Tang Y, Zhu G, Zheng M, et al. (2012) Coexpression of hypoxia-inducible factor-2alpha, TWIST2, and SIP1 may correlate with invasion and metastasis of salivary adenoid cystic carcinoma. J Oral Pathol Med 41: 424-431.
13. Liang X, Zheng M, Jiang J, Zhu G, Yang J, et al. (2011) Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. Oral Oncol 47: 92-97.
14. Gasparotto D, Polesel J, Marzotto A, Colladel R, Piccinin S, et al. (2011) Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas. Oncotarget 2: 1165-1175.
15. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, et al. (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 213: 374-383. (Pubitemid 47509716)
16. Giehl K, Menke A (2008) Microenvironmental regulation of E-cadherin-mediated adherens junctions. Front Biosci 13: 3975-3985. (Pubitemid 351594675)
17. Chaw SY, Majeed AA, Dalley AJ, Chan A, Stein S, et al. (2012) Epithelial to mesenchymal transition (EMT) biomarkers-E-cadherin, beta-catenin, APC and Vimentin-in oral squamous cell carcinogenesis and transformation. Oral Oncol 48: 997-1006.
18. Orsulic S, Huber O, Aberle H, Arnold S, Kemler R (1999) E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1- mediated transactivation. J Cell Sci 112 (Pt 8): 1237-1245. (Pubitemid 29218912)
19. Pon YL, Zhou HY, Cheung AN, Ngan HY, Wong AS (2008) p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells. Cancer Res 68: 6524-6532.
20. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, et al. (2001) The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7: 1267-1278. (Pubitemid 32607360)
21. Shimokawa M, Haraguchi M, Kobayashi W, Higashi Y, Matsushita S, et al. (2012) The transcription factor Snail expressed in cutaneous squamous cell carcinoma induces epithelial-mesenchymal transition and down-regulates COX-2. Biochem Biophys Res Commun.
22. Miyoshi A, Kitajima Y, Sumi K, Sato K, Hagiwara A, et al. (2004) Snail and SIP1 increase cancer invasion by upregulating MMP family in hepatocellular carcinoma cells. Br J Cancer 90: 1265-1273. (Pubitemid 38496823)
23. Huang W, Zhang Y, Varambally S, Chinnaiyan AM, Banerjee M, et al. (2008) Inhibition of CCN6 (Wnt-1-induced signaling protein 3) down-regulates Ecadherin in the breast epithelium through induction of snail and ZEB1. Am J Pathol 172: 893-904. (Pubitemid 351519987)
24. Vesuna F, van Diest P, Chen JH, Raman V (2008) Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun 367: 235-241.
25. Mao Y, Zhang N, Xu J, Ding Z, Zong R, et al. (2012) Significance of heterogeneous Twist2 expression in human breast cancers. PLoS One 7: e48178.
26. Mao Y, Xu J, Song G, Zhang N, Yin H (2013) Twist2 promotes ovarian cancer cell survival through activation of Akt. Oncol Lett 6: 169-174.
27. Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, et al. (2007) KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. Cancer Res 67: 11064-11073. (Pubitemid 350145937)
28. Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28: 151-166.
29. Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, et al. (2005) beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24: 8200-8204. (Pubitemid 41759818)
30. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
31. Gordon MD, Nusse R (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281: 22429-22433.
32. Tran TH, Jarrell A, Zentner GE, Welsh A, Brownell I, et al. (2010) Role of canonical Wnt signaling/ss-catenin via Dermo1 in cranial dermal cell development. Development 137: 3973-3984.
33. Song G, Ouyang G, Mao Y, Ming Y, Bao S, et al. (2009) Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation. J Cell Mol Med 13: 1706-1718.
34. Mao Y, Song G, Cai Q, Liu M, Luo H, et al. (2006) Hydrogen peroxide-induced apoptosis in human gastric carcinoma MGC803 cells. Cell Biol Int 30: 332-337.
35. Xia W, Liu Z, Zong R, Liu L, Zhao S, et al. (2011) Truncated ErbB2 Expressed in Tumor Cell Nuclei Contributes to Acquired Therapeutic Resistance to ErbB2 Kinase Inhibitors. Mol Cancer Ther 10: 1367-1374.
36. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, et al. (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55: 611-622.